Regen BioPharma Inc (RGBP)

[cvinvestor]

Well, at least with the bump in volume activity the past 3 days, we haven't lost price value which is a good sign in and of itself.

New month tomorrow can bring new funds.

September is last month of 3rd Qtr. We'll see if the outlay by Lander of HemaXellerate beginning trials in 3rd Qtr comes true or not. He had said modified HemaX IND was expected to be approved in 4th Qtr, but they hadn't submitted it yet and no update on Orphan Drug Status which was filed back in Jan 2016, so still don't know what to really believe as far as timing goes.

Hoping for the best.

cv